Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/1996
06/20/1996WO1996018651A1 Human somatostatin-like receptor
06/20/1996WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
06/20/1996WO1996018418A1 Improved adenoviral vectors and producer cells
06/20/1996CA2206683A1 Improved adenoviral vectors and producer cells
06/20/1996CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling
06/20/1996CA2165374A1 Restricted 9-cis-retenoids
06/19/1996EP0717034A1 Vitamin D compounds and method of preparing these compounds
06/19/1996EP0716855A2 Use of estrogen agonists for treating prostatic disease, obesity and bone loss
06/19/1996EP0716694A1 Human glucagon-like 1 peptide receptor
06/19/1996EP0716649A1 5-arylindole derivatives
06/19/1996EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY
06/19/1996EP0716606A1 Phosphate-binding polymers for oral administration
06/19/1996EP0716603A1 Methods and compositions for inhibiting uridine secretion
06/19/1996EP0489089B1 Therapeutic peptides
06/19/1996CN1124978A Cell matrix stimulated cell attachment and hemidesmosome assembly
06/19/1996CN1124927A Analogs of peptide YY and uses thereof
06/18/1996US5527804 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or cholesterol absorption
06/18/1996US5527803 Immunosuppressants, phosphorylase inhibitors
06/18/1996US5527784 Antihyperlipidemic and antiobesity agent comprising levan or hydrolysis products thereof obtained from Streptococcus salivarius
06/18/1996CA1338376E Regimen for treating osteoporosis
06/15/1996CA2164916A1 Vitamin d compounds and method of preparing these compounds
06/13/1996WO1996017931A1 Human vascular ibp-like growth factor
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017603A1 Emulsion suitable for administering a sphingolipid and use thereof
06/13/1996WO1996012697A3 Calcium receptor-active compounds
06/12/1996EP0715624A1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine
06/12/1996EP0715620A1 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
06/12/1996EP0556322B1 Aminosulfonyl urea acat inhibitors
06/12/1996EP0451203B1 Modulation of adenylate cyclase response
06/12/1996CN1124488A New thiazolidindiones and drugs containing them
06/12/1996CN1124148A Healthy medicated wine
06/12/1996CN1032000C Process for preparing pyrazolidinone CCK and gastrin antagonists
06/12/1996CN1031998C |Alpha-(tert-butyl aminomethyl)-3,4-dichloro benzyl¨ thioacetamide, process for preparing them and application
06/06/1996WO1996017054A1 Method and compositions for reducing cholesterol absorption
06/06/1996WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases
06/06/1996WO1996016952A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
06/06/1996CA2206526A1 Method and compositions for reducing cholesterol absorption
06/06/1996CA2205799A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/05/1996EP0714883A1 Aryloxypropanolamine beta 3 adrenergic agonists
06/05/1996EP0714663A2 Potentiation of drug response by a serotonin 1A receptor antagonist
06/05/1996EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles
06/05/1996EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells
06/05/1996EP0714404A1 Anti-inflammatory peptides
06/05/1996EP0714391A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists
06/05/1996EP0714294A1 Pharmaceutical compositions comprising metal complexes
06/05/1996EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
06/05/1996EP0714240A1 Reduced absorption of fatty acids
06/05/1996CN1124006A Cholesterol lowering drink mix compositions
06/05/1996CN1123793A Non-reducing oligosaccharide and its production and use
06/04/1996US5523407 Quinoline derivatives, their production and use as ACAT inhibitors
06/04/1996US5523306 Amino acid derivatives cyclized at the C-terminal
06/04/1996US5523099 Stability, reduced sweetness, appropriate viscosity, non-crystallizing and less fermentabiity; foods, beverages, cosmetics and drugs
06/03/1996CA2164246A1 Aryloxypropanolamine beta 3 adrenergic agonists
05/1996
05/30/1996WO1996016051A1 Hypolipidemic benzothiazepines
05/30/1996WO1996016037A1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
05/30/1996WO1996016036A1 18-nor-vitamin d compounds
05/30/1996WO1996016035A1 18,19-dinor-vitamin d compounds
05/30/1996WO1996016031A1 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
05/30/1996WO1996016027A1 Matrix metalloprotease inhibitors
05/30/1996WO1996015804A1 Acylated insulin analogs
05/30/1996WO1996015784A3 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance
05/30/1996WO1996015784A2 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance
05/30/1996CA2206876A1 18,19-dinor-vitamin d compounds
05/30/1996CA2206873A1 18-nor-vitamin d compounds
05/30/1996CA2205060A1 Acylated insulin analogs
05/30/1996CA2202265A1 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
05/29/1996EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them
05/29/1996EP0713699A2 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
05/29/1996EP0713653A1 Fortified fruit juice
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/29/1996EP0679089A4 Methods for promoting cartilage matrix formation.
05/29/1996EP0521967B1 New use of bambuterol
05/29/1996EP0490955B1 Treatment of insulin-resistant diabetes
05/29/1996EP0469065B1 Recombinant antibody-toxin fusion protein
05/29/1996CA2163840A1 Potentiation of drug response
05/28/1996US5521315 Olefin substituted long chain compounds
05/28/1996US5521216 Treating complications of diabetes
05/28/1996US5521172 Benzothiophene ketones with benzene derivatives
05/28/1996US5521170 Benzamide derivatives and pharmaceutical composition comprising the same
05/28/1996US5521071 Soluble LDL receptor and gene
05/28/1996US5520948 High acid system nutritional formulations
05/28/1996CA2078996C A bifunctional dtpa-type ligand
05/25/1996CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/24/1996CA2163466A1 Fortified fruit juices
05/23/1996WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996WO1996015147A1 Human stanniocalcin-alpha
05/23/1996WO1996015141A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents
05/23/1996WO1996015127A1 Pyridazinoquinoline compounds
05/23/1996WO1996014846A1 Dihydropyrimidines and uses thereof
05/23/1996CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996CA2202135A1 Pyridazinoquinoline compounds
05/22/1996EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
05/22/1996EP0712864A2 Non-absorbable synthetic sulfated polysaccharides
05/22/1996EP0712861A2 Acylated insulin analogs
05/22/1996EP0712628A2 Methods of inhibiting bone loss
05/22/1996EP0712627A2 Methods for lowering serum cholesterol
05/22/1996EP0712583A2 Total parenteral nutrition solution containing watersoluble vitamin B
05/22/1996EP0712303A1 Skin patches and methods for providing testosterone
05/22/1996EP0637299B1 20-methyl-substituted vitamin d derivates
1 ... 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 ... 1298